National University Cancer Institute

Singapore (Singapore sg)

Bibliometric indicators

Evolution over the last years of activity

Showing the period - Sept. 2024

4,768
Activity
3%

Total documents

2.25
Impact
3%

Normalized Impact

1,113
Excellence
3%

Highly Cited Papers (Top 10%)

69.5
Leadership
3%

Leadership (%)

65.6
Mobility & Collaboration
3%

International Collaboration (%)

157
Excellence
3%

Outstanding papers (Top 1%)

7.6
Leadership
3%

Women Leading (%)

4.5
Leadership
3%

Women Leading International (%)

63.9
Open Access
3%

Open Access (%)

Main Research Fields (top 9 by publications)

Indicators:

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Human Resources

Historical perspective

From to Sept. 2024

Current resources

Quick filters

Career Stage
Occasional Junior Researcher Senior Leading
Performance
Standard Good Excellent Outstanding
Gender
Male Female
Reset
0

Personnel

0.0

Papers / Personnel

0

Leading women (%)

0
0

Gender (%)

0

Papers / Permanent researchers

0

Papers / Leading researchers

Career stage

Performance

Years of Activity

ONE Index (distribution)

ONE Index by Main Research Fields

ONE Index vs. Years of Activity

Main authors

ID Name Gender Discipline Career Stage ONE Index Years Activity NDocs RCI HCP Leader Collab.
1 Lee, Soo Chin male Oncology Senior researcher 880 25 284 2.26 58 33.5% 47.9%
2 Chng, Wee Joo male Molecular Biology Senior researcher 878 27 682 2.29 129 39.2% 45.9%
3 Soo, Ross male Pulmonary and Respiratory Medicine, Oncology Senior researcher 871 26 472 2.56 89 26.7% 62.3%
4 Tan, David male Oncology Leading researcher 863 26 308 2.29 48 40.9% 46.4%
5 Yong, Wei Peng male Molecular Biology, Oncology Researcher 847 26 355 2.45 68 26.2% 46.5%
6 Goh, Boon Cher male Molecular Biology, Oncology Senior researcher 841 26 341 2.52 67 25.2% 44.6%
7 Jeyasekharan, Anand male Molecular Biology Senior researcher 835 20 157 1.48 30 39.5% 44.0%
8 Sundar, Raghav male Oncology Senior researcher 830 27 243 1.96 52 32.1% 48.6%
9 Vellayappan, Balamurugan male Pulmonary and Respiratory Medicine, Surgery Researcher 818 13 151 0.96 14 41.1% 39.7%
10 Lu, Jiade J Surgery, Pulmonary and Respiratory Medicine, Oncology Senior researcher 812 26 361 1.27 49 38.5% 28.3%
11 Bassal, Mahmoud Adel male Molecular Biology Researcher 767 10 46 1.34 14 21.7% 93.5%
12 Ngoi, Natalie Yan Li female Oncology Researcher 755 12 102 0.89 12 32.4% 52.0%
13 Tey, Jeremy male Pulmonary and Respiratory Medicine Senior researcher 734 18 154 0.73 10 40.9% 20.1%
14 Chan, Natalie female Public Health, Environmental and Occupational Health Senior researcher 712 16 52 2.34 10 30.8% 34.6%
15 Yap, Eng Soo male Hematology, Infectious Diseases Senior researcher 709 17 90 1.41 11 31.1% 32.2%
16 Koh, Liang Piu male Hematology Senior researcher 705 26 148 1.25 16 23.7% 31.1%
17 Soon, Yu Yang male Pulmonary and Respiratory Medicine Senior researcher 702 23 164 0.71 14 32.3% 18.3%
18 Winston T. H. Koh Pulmonary and Respiratory Medicine, Economics and Econometrics Leading researcher 700 34 204 0.63 19 58.3% 13.7%
19 Chee, Cheng Ean male Oncology Leading researcher 692 31 126 1.69 21 24.6% 40.5%
20 Nesaretnam Barr Kumarakulasinghe Oncology Researcher 691 10 45 1.31 8 11.1% 37.8%
21 Goh, Boon-Cher Molecular Biology, Oncology Senior researcher 689 23 68 2.43 18 41.2% 42.7%
22 de Mel, Sanjay male Senior researcher 688 27 153 0.73 14 35.3% 39.2%
23 Lim, Jhin Jieh male Molecular Biology Researcher 684 8 27 1.47 5 33.3% 22.2%
24 Li En Yvonne Ang Family Practice Occasional author 684 5 3 1.98 1 0.0% 0.0%
25 Heong, Valerie female Oncology Senior researcher 671 15 55 2.80 5 29.1% 41.8%
880
One Index
Lee, Soo Chin PhD   0000-0002-5835-6419 284 docs (2000 - 2024)  
Breast Cancer , Cancer Risk , cancer susceptibility , Trastuzumab , Genetic Testing
878
One Index
Chng, Wee Joo PhD   0000-0003-2578-8335 682 docs (1998 - 2024)  
International Myeloma Working Group , Priming (agriculture) , Daratumumab , Multidrug Resistance , Ixazomib
871
One Index
Soo, Ross PhD   0000-0002-3053-3997 472 docs (1999 - 2024)  
EGFR Mutations , Osimertinib , T790M , Afatinib , Biomarker Analysis
863
One Index
Tan, David PhD   0000-0001-9087-5262 308 docs (1999 - 2024)  
Breast Cancer , Olaparib , Tumor Models , Tolerability , Carboplatin
847
One Index
Yong, Wei Peng PhD   0000-0003-4404-3777 355 docs (1999 - 2024)  
Gastric Cancer , Tolerability , Intraperitoneal Chemotherapy , Hyperthermic Intraperitoneal Chemotherapy , Clinical endpoint
841
One Index
Goh, Boon Cher PhD   0000-0002-4107-102X 341 docs (1999 - 2024)  
Cancer Therapy , Tolerability , Cancer , Breast Cancer , Lenvatinib
835
One Index
Jeyasekharan, Anand PhD   0000-0001-9816-6137 157 docs (2005 - 2024)  
BCL6 , B-Cell Receptor Signaling , Gene Expression Profiling , Cell Heterogeneity , Intratumor Heterogeneity
830
One Index
Sundar, Raghav PhD   0000-0001-9423-1368 243 docs (1998 - 2024)  
Tolerability , RNA Editing , mRNA modification , Intraperitoneal Chemotherapy , Hyperthermic Intraperitoneal Chemotherapy
818
One Index
Vellayappan, Balamurugan PhD   0000-0002-1077-1840 151 docs (2012 - 2024)  
Radiotherapy , Metastatic Spine Tumors , Metastatic Epidural Spinal Cord Compression , Spinal Metastases , Brain Metastases
812
One Index
Lu, Jiade J PhD   0000-0001-7163-9539 361 docs (1999 - 2024)  
Radiotherapy , Nasopharyngeal Carcinoma , Carbon Ion Radiotherapy , Image-Guided Radiotherapy , Chemoradiotherapy
767
One Index
Bassal, Mahmoud Adel PhD   0000-0003-4322-2968 46 docs (2015 - 2024)  
RNA methylation , DNA Methylation , mRNA modification , Gene Expression Regulation , DNA demethylation
755
One Index
Ngoi, Natalie Yan Li PhD   0000-0003-2071-0715 102 docs (2013 - 2024)  
Lenvatinib , Breast Cancer , Letrozole , Olaparib , Platinum-Sensitive Ovarian Cancer
734
One Index
Tey, Jeremy PhD   0000-0003-1363-446X 154 docs (2007 - 2024)  
Radiotherapy , Chemoradiotherapy , Gastric Cancer , Metastatic Gastric Cancer , Clinical endpoint
712
One Index
Chan, Natalie PhD   0000-0003-0009-4695 52 docs (2009 - 2024)  
End-of-life care , Advance Care Planning , Personhood , Depression (economics) , PsycINFO
709
One Index
Yap, Eng Soo PhD   0000-0002-7910-3154 90 docs (2008 - 2024)  
Paroxysmal nocturnal hemoglobinuria , Dengue , Venous Thromboembolism , Eculizumab , Stroke (engine)
705
One Index
Koh, Liang Piu PhD   0000-0002-8298-647X 148 docs (1999 - 2024)  
Hematopoietic Cell Transplantation , Regimen , Cord blood , Cumulative incidence , Total body irradiation
702
One Index
Soon, Yu Yang PhD   0000-0002-1995-2170 164 docs (2002 - 2024)  
Radiotherapy , Chemoradiotherapy , Non-Small Cell Lung Cancer , Subgroup analysis , EGFR Mutations
700
One Index
Winston T. H. Koh PhD 204 docs (1991 - 2024)  
Radiotherapy , EGFR Mutations , Durable good , Metastatic Gastric Cancer , Non-Small Cell Lung Cancer
692
One Index
Chee, Cheng Ean PhD   0000-0003-2385-7712 126 docs (1994 - 2024)  
CEBPA , Tolerability , Lenvatinib , Intraperitoneal Chemotherapy , Hyperthermic Intraperitoneal Chemotherapy
691
One Index
Nesaretnam Barr Kumarakulasinghe PhD 45 docs (2015 - 2024)  
Tolerability , EGFR Mutations , Nasopharyngeal Carcinoma , Metastatic Epidural Spinal Cord Compression , Patient Participation
689
One Index
Goh, Boon-Cher PhD 68 docs (2002 - 2024)  
Pharmacodynamics , Cancer Therapy , Tumor Microenvironment , HDAC Inhibitors , Pharmacogenetics
688
One Index
de Mel, Sanjay PhD   0000-0002-8881-3537 153 docs (1998 - 2024)  
BCL6 , B-Cell Receptor Signaling , International Myeloma Working Group , Cell Heterogeneity , Gene Expression Profiling
684
One Index
Lim, Jhin Jieh PhD   0000-0002-7164-508X 27 docs (2017 - 2024)  
Cancer Epigenetics , Liver cancer , Lopinavir , Epigenetic Therapy , Epigenetic Reprogramming
684
One Index
Li En Yvonne Ang 3 docs (2020 - 2021)  
Medication Adherence , Treatment Adherence , Barriers to Adherence , Medication Persistence , Exploratory factor analysis
671
One Index
Heong, Valerie PhD   0000-0001-8894-1355 55 docs (2010 - 2024)  
Tumor Models , Cancer Therapy , Intratumor Heterogeneity , ATM and ATR Kinases , Tolerability